IRIS PubliCatt

Autore, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.161
EU - Europa 1.682
AS - Asia 593
AF - Africa 29
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 4.482
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.149
SE - Svezia 456
CN - Cina 371
IT - Italia 370
DE - Germania 173
IE - Irlanda 148
SG - Singapore 119
FR - Francia 112
UA - Ucraina 97
GB - Regno Unito 85
RU - Federazione Russa 72
PL - Polonia 54
FI - Finlandia 43
IN - India 33
CI - Costa d'Avorio 25
TR - Turchia 22
CZ - Repubblica Ceca 14
BE - Belgio 12
HK - Hong Kong 12
JP - Giappone 12
CA - Canada 10
NL - Olanda 9
ES - Italia 8
IR - Iran 8
BR - Brasile 6
AT - Austria 5
HU - Ungheria 5
GR - Grecia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
IL - Israele 3
KR - Corea 3
RO - Romania 3
CL - Cile 2
EG - Egitto 2
MD - Moldavia 2
MX - Messico 2
NO - Norvegia 2
PK - Pakistan 2
VN - Vietnam 2
AR - Argentina 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MT - Malta 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.482
Salva come PNG Salva come JPEG
Città #
Chandler 512
Ashburn 173
Dublin 145
Beijing 85
Wilmington 83
Jacksonville 80
Dearborn 76
Ann Arbor 75
San Mateo 75
Florence 74
Nanjing 73
Singapore 69
Cattolica 67
Lancaster 66
Rome 65
Warsaw 54
Boston 53
Princeton 52
Milan 49
Fairfield 46
Woodbridge 46
New York 41
Moscow 40
Marseille 39
Nanchang 37
Seattle 33
Houston 31
Bremen 28
Los Angeles 27
Abidjan 25
Lawrence 25
Redwood City 25
Kunming 21
Cambridge 20
Munich 19
Izmir 18
Auburn Hills 17
Redmond 17
Boardman 16
Pune 16
Shenyang 15
Helsinki 14
Norwalk 13
Washington 13
Brussels 12
Hefei 12
Hangzhou 11
Mountain View 11
Tianjin 10
Brno 9
Hebei 9
Hong Kong 9
Kyoto 9
Chicago 8
Saint Petersburg 8
Zhengzhou 8
Jiaxing 7
Shanghai 7
Guangzhou 6
London 6
Napoli 6
Budapest 5
North Hollywood 5
Pavia 5
Phoenix 5
Toronto 5
Amsterdam 4
Brdo 4
Changsha 4
Engelhard 4
Frankfurt am Main 4
Fuzhou 4
Jinan 4
Lanzhou 4
Lappeenranta 4
San Francisco 4
Augusta 3
Bangalore 3
Bogotá 3
Central 3
Changchun 3
Clifton 3
Garden City 3
Jiangyin 3
Kish 3
Leawood 3
Monmouth Junction 3
Naples 3
San Marzano sul Sarno 3
Seville 3
Stockholm 3
São Paulo 3
Vancouver 3
Vigo 3
Andover 2
Arcueil 2
Atlanta 2
Bagnacavallo 2
Bloomfield 2
Brookline 2
Totale 2.847
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 281
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 134
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 102
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 101
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 99
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 90
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 87
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 86
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 78
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 77
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 70
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 68
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 68
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 67
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 66
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 66
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 64
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 63
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 62
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 62
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 61
Unrelated cord blood transplantation and post-transplant cyclophosphamide 61
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 60
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 60
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 59
Unrelated cord blood transplantation and post-transplant cyclophosphamide 59
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 58
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 56
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 55
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 54
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 54
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 54
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 53
the concomitance of lymphoma and breast carcinoma in the bone 53
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 51
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 51
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 51
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 50
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 48
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 46
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 46
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 45
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 44
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 44
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 44
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 43
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 43
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 43
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 42
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 42
The concomitance of lymphoma and breast carcinoma in the bone 41
Second haploidentical stem cell transplantation for primary graft failure 41
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 41
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience 40
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 39
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 39
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 39
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 39
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 39
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 39
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 38
New developments in the management of chronic lymphocytic leukemia: Role of ofatumumab 37
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 37
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 36
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 35
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 34
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. 34
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 34
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 34
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 33
'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy 32
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 31
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia 31
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. 28
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 28
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review 27
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 27
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 26
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 25
Richter transformation in Chronic Lymphocytic Leukemia 23
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 23
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia 23
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 22
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 21
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 20
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 20
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 19
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 18
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 17
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 16
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 15
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 15
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis 15
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 11
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 11
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 5
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 5
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 5
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation 5
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 4
Totale 4.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020578 0 53 48 75 57 81 61 27 36 42 63 35
2020/2021317 20 30 11 20 66 29 15 5 33 13 62 13
2021/2022597 51 15 26 24 51 5 7 89 32 33 136 128
2022/20231.466 203 190 107 205 103 196 81 94 168 34 64 21
2023/2024903 39 225 65 77 39 135 66 22 16 35 82 102
2024/202568 52 16 0 0 0 0 0 0 0 0 0 0
Totale 4.642